Literature DB >> 12384493

Rat model of pulmonary arteriovenous malformations after right superior cavopulmonary anastomosis.

Sandra L Starnes1, Brian W Duncan, Charles H Fraga, Shailesh Y Desai, Thomas K Jones, Sanjeev K Mathur, Geoffrey L Rosenthal, Flavian M Lupinetti.   

Abstract

We developed a rat model of pulmonary arteriovenous malformations after cavopulmonary anastomosis. We sought to determine whether this model reproduces the angiographic and histologic features seen in the human condition. Eight Sprague-Dawley rats underwent a right superior cavopulmonary anastomosis with the use of microsurgical techniques. Between 2 and 13 mo, pulmonary angiography was performed, the animals were euthanized, and the lungs were removed. Microscopic sections of the lung were stained with an endothelial-specific antibody (von Willebrand factor). Microvessel density was determined by counting vessels staining positively for von Willebrand factor, and the shunted and nonshunted (control) lungs were compared for each animal. Pulmonary angiography revealed time-dependent development of arteriovenous malformations. Microvessel density demonstrated a time-dependent increase in the shunted lung compared with the control lung (simple linear regression of the ratio of the microvessel density of the shunted lung divided by the microvessel density of the control lung on time; R(2) = 0.79, P = 0.003). This animal model reproduces the same angiographic and microscopic features of pulmonary arteriovenous malformations that develop in humans after cavopulmonary anastomosis. This appears to be a valid model that may be used to further study etiologic mechanisms for this phenomenon.

Entities:  

Mesh:

Year:  2002        PMID: 12384493     DOI: 10.1152/ajpheart.00368.2002

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  8 in total

1.  Morphological studies of pulmonary arteriovenous shunting in a lamb model of superior cavopulmonary anastomosis.

Authors:  S M Bradley
Journal:  Pediatr Cardiol       Date:  2008-07       Impact factor: 1.655

Review 2.  Pulmonary arteriovenous malformations after the superior cavopulmonary shunt: mechanisms and clinical implications.

Authors:  Minoo N Kavarana; Jeffrey A Jones; Robert E Stroud; Scott M Bradley; John S Ikonomidis; Rupak Mukherjee
Journal:  Expert Rev Cardiovasc Ther       Date:  2014-04-23

3.  Abnormalities in the Von Willebrand-Angiopoietin Axis Contribute to Dysregulated Angiogenesis and Angiodysplasia in Children With a Glenn Circulation.

Authors:  Carlo R Bartoli; Samson Hennessy-Strahs; Robert D Dowling; J William Gaynor; Andrew C Glatz
Journal:  JACC Basic Transl Sci       Date:  2021-03-22

4.  Constitutively active endothelial Notch4 causes lung arteriovenous shunts in mice.

Authors:  Doug Miniati; Eric B Jelin; Jennifer Ng; Jianfeng Wu; Timothy R Carlson; Xiaoqing Wu; Mark R Looney; Rong A Wang
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-11-20       Impact factor: 5.464

5.  Reconstruction of cavopulmonary pathway for the patient with persistent arteriovenous malformations due to offset flow from hepatic vein.

Authors:  Narutoshi Hibino; Pranava Sinha; Mary Donofrio; Richard A Jonas
Journal:  J Saudi Heart Assoc       Date:  2011-10-21

6.  Morphological studies of pulmonary arteriovenous shunting in a lamb model of superior cavopulmonary anastomosis.

Authors:  David Michael McMullan; Vadiyala Mohan Reddy; William M Gottliebson; Norman H Silverman; Stanton B Perry; Frandics Chan; Frank Louis Hanley; Robert Kirk Riemer
Journal:  Pediatr Cardiol       Date:  2007-11-28       Impact factor: 1.655

Review 7.  Is the Hepatic Factor a miRNA that Maintains the Integrity of Pulmonary Microvasculature by Inhibiting the Vascular Endothelial Growth Factor?

Authors:  Joseph J Vettukattil
Journal:  Curr Cardiol Rev       Date:  2017

Review 8.  Pulmonary Vascular Sequelae of Palliated Single Ventricle Circulation: Arteriovenous Malformations and Aortopulmonary Collaterals.

Authors:  Andrew D Spearman; Salil Ginde
Journal:  J Cardiovasc Dev Dis       Date:  2022-09-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.